Global Depression Treatment Therapy Market Research and Forecast, 2018-2023

Depression treatment market is facing stiff decline. The market is expected to grow at low CAGR of 2.1% for the forecasted period of 2018-2023. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The patent cliff has caused a decline in revenues ranging from few million dollars to billions. The patent expiration and generic drug manufacturers gaining license to manufacturers have forced many branded drug manufacturers to either stop their R&D or to reduce budgets. There are very limited number of new drugs in the pipeline. Decline in revenues is majorly due to fall in the price of once expensive drugs by over 50-90%. Volume shipment is still high and increasing especially in emerging markets.

However, markets for therapies using medical devices such as Vagus nerve stimulation, deep brain stimulation, and smartphones is rising. The devices market is expected to grow at a CAGR of 9.2%. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is also driving the market.

North America and Europe currently are the leading markets. They make up for 70% of the total depression treatment market. The markets are driven by high awareness regarding depression and availability of drugs and therapies. However, the patent cliff has caused a decline in the growth rates of the market. Asia Pacific will have the highest growth rate. Recently the discussion over effects of depression on the economies has been going on. Countries such as India, China and Japan are spending on the research of new treatment methods for treating depression. It is expected that new Asian companies could develop new branded drugs in the near future.

Some Brief Table of Contents of Report

1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN

2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.6. REGULATIONS

3. MARKET DETERMINANT
3.1. MOTIVATORS
3.2. RESTRAINTS
3.3. OPPORTUNITIES

4. MARKET SEGMENTATION
4.1. DEPRESSION TREATMENT THERAPY MARKET BY DEPRESSION TYPE
4.2. DEPRESSION TREATMENT THERAPY MARKET BY DRUGS TYPE
4.3. DEPRESSION TREATMENT THERAPY MARKET BY DEPRESSION TREATMENT DEVICE

TOC Continued....

Browse full report at: https://www.omrglobal.com/industry-reports/global-depression-treatment-market/

Related Reports: https://www.omrglobal.com/reports-category/pharmaceuticals/

For More Updates Follow LinkedIn: www.linkedin.com/company/omr-global-research/

About Orion Market Research

“OMR is a market research company known for its qualitative and quantitative research reports. The company aims to provide business insights for decision making to our global clients. OMR provides syndicated and customized research reports, company profiling, consulting and other research-based services to global clients. At OMR, we believe in overcoming the competition by delivering quality reports on time. The “Orion” in our name signifies rising up in the sky, we are committed to providing valuable insights that will help you rise and shine. We follow our core values to achieve the aim of providing best solution and satisfaction to our clients by maintaining quality reports in stipulated time. OMR provide customer-centric reports which facilitate our subscribers to know their touch points which can be capitalized for their revenue growth and to gain a competitive edge. Our thorough analysis starts right from grass root level where in we extend lens not only to our clients but also to the customer of our clients, this exclusiveness helps our subscribers in effective decision making and to improve business strategy.”

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667

This release was published on openPR.